COVID-19

Update from the Dean: Back to school

Thu Aug 13, 2020

Dean B. Joseph Guglielmo, PharmD

Dean Guglielmo provides updates on ongoing efforts with science, education, and patient care in the School.

Nanobody-based antiviral developed at UCSF effectively blocks SARS-CoV-2 in the lab

Wed Aug 12, 2020

Noah Berger

The antiviral invented by Aashish Manglik, PhD, and colleagues is effective at blocking SARS-CoV-2 infection even as an aerosolized spray, according to laboratory testing.

School scientists developed an antiviral that fights SARS-CoV-2 that can be given as a nasal spray.

How targeting a key SARS-CoV-2 enzyme could lead to an antiviral drug

Fri Jul 10, 2020

Elisabeth Fall

James Fraser, PhD

The chemical fragments could bind to and disable an enzyme that helps the virus replicate.

SARS-CoV-2 may spur growth of molecular “railways” out of infected cells, School scientists show

Thu Jul 2, 2020

NIAID/NIH

SARS-CoV-2 viral particles and human cells

UCSF-led collaboration uncovers new avenues for COVID-19 drug discovery

COVID-19 relies on cell’s ‘master regulators’ for survival

Tue Jun 30, 2020

School of Pharmacy serves as PPE distribution hub for community pharmacies

Fri Jun 26, 2020

School faculty, staff, and PharmD students repackaged and distributed personal protective equipment to local pharmacies. From left to right: Julie Erich, Marley Quirante, Christine Vo, and Ernie Lum.

The School collaborates with the State of California and the California Pharmacists Association to provide vital PPE supplies to local pharmacies.

Update from the Dean: Confronting racism and health inequities

Fri Jun 19, 2020

Elisabeth Fall

Dean B. Joseph Guglielmo, PharmD

Our COVID-19 response: A commitment to anti-racist action

Pharmacies for COVID-19 care

Thu Jun 18, 2020

Bay Area must enable economic, equitable recovery

Mon Jun 15, 2020

QBI Coronavirus Research Group identifies drugs that block SARS-CoV-2 in the laboratory

Thu May 28, 2020

Susan Merrell

Nevan Krogan, PhD (standing), leads a meeting of the QBI Coronavirus Research Group with fellow UCSF faculty members (seated from left) Danica Galonić Fujimori, PhD; Natalia Jura, PhD; James Fraser, PhD; and David Agard, PhD.

The QBI Coronavirus Research Group found six drugs that effectively beat back SARS-COV-2 in the laboratory.

Topics and Expertise: COVID-19